Continuous Glucose Monitoring Update – Why it Will Soon Become Standard Care
Optimise insulin-treated T2D care with CGM initiation and device selection.
Availability
On-Demand
Release on Dec 20, 2026 2:00 PM Malay Peninsula Standard Time
Cost
$0.00
CPD Offered
0.5 CPD Hour
  • Overview
Continuous glucose monitoring (CGM) is now being recommended as the standard for management of any patient on intensive insulin therapy, not just those with type 1 diabetes. In this lecture, A/Prof Gary Kilov AM will present the evidence that supports current guidelines for CGM to be used in patients with type 2 diabetes who are on insulin. He will also address the logistics of commencing CGM in this cohort - including the when, how, for how long and choice of device. An important update in a rapidly evolving area of medicine.

A/Prof Gary Kilov AM

A/Prof Gary Kilov AM is a founding member of the RACGP (Royal Australian College of GPs) Diabetes Specific Interest Group and a co-founder of the Primary Care Diabetes Society of Australia and past Editor in Chief of the Society’s journal, Diabetes & Primary Care Australia. He is a contributor to the current RACGP diabetes handbook (2016-2024) and a member of several National Diabetes Supply Scheme Expert Reference Groups. He has presented papers and conducted numerous educational sessions at national and international seminars and conferences, and he has been published in peer-reviewed journals on topics related to diabetes, obesity, and respiratory medicine.

 

 

Powered By